International clinical psychopharmacology

Keyphrases

Publications

2024

Jemma E Reid, Luca Pellegrini, Lynne Drummond, Yana Varlakova, Sonia Shahper, David S Baldwin, Christopher Manson, Samuel R Chamberlain, Trevor W Robbins, David Wellsted, Naomi A Fineberg
Differential effects of sertraline and cognitive behavioural therapy on behavioural inhibition in patients with obsessive compulsive disorder. International clinical psychopharmacology (2024)
Alberto Sainz-Cort, Marta Martín-Islas, Daniel Jimenez-Garrido, Miriam López-Navarro, Genís Oña, Elena Muñoz-Marron, Luis Heredia, Mercè Gil-Pérez, Margarita Torrente, Paloma Vicens, José Carlos Bouso
Validation of the Spanish version of the multifaceted empathy test: comparison between cannabis use effects and controls in social cognition. International clinical psychopharmacology (2024)
Jemma E Reid, Luca Pellegrini, Lynne Drummond, Yana Varlakova, Sonia Shahper, David S Baldwin, Christopher Manson, Samuel R Chamberlain, Trevor W Robbins, David Wellsted, Naomi A Fineberg
Differential effects of sertraline and cognitive behavioural therapy on behavioural inhibition in patients with obsessive compulsive disorder. International clinical psychopharmacology (2024)
Karim Abdel Aziz, Hind Mohd Ahmed, Emmanuel Stip, Dina Aly El-Gabry
Metabolic syndrome and its relation to antipsychotic polypharmacy in schizophrenia, schizoaffective and bipolar disorders. International clinical psychopharmacology (2024)
Toshinori Nakamura, Yusuke Arai, Tetsuya Hagiwara, Ryosuke Kitoh, Daimei Sasayama, Shinsuke Washizuka
Parasomnia induced by lemborexant: a case report. International clinical psychopharmacology (2024)
Veronika Matuskova, Martin Vyhnalek
Towards a replicable protocol to identify patients with psychiatric disorders at higher risk of developing dementia. International clinical psychopharmacology (2024)
Enrico Capuzzi, Cecilia Quitadamo, Alice Caldiroli, Massimo Clerici, Massimiliano Buoli
The impact of efficacy of long-acting injectable antipsychotics on caregivers' burden of patients with schizophrenia. International clinical psychopharmacology (2024)
Sabrina Wong, Gia Han Le, Angela T H Kwan, Taeho Greg Rhee, Kayla M Teopiz, Roger C Ho, Bing Cao, Joshua D Rosenblat, Rodrigo Mansur, Roger S McIntyre
Risk of VMAT2 inhibitors on suicidality and parkinsonism: report utilizing the United States Food and Drug Administration adverse event reporting system. International clinical psychopharmacology (2024)
Jemma E Reid, Luca Pellegrini, Lynne Drummond, Yana Varlakova, Sonia Shahper, David S Baldwin, Christopher Manson, Samuel R Chamberlain, Trevor W Robbins, David Wellsted, Naomi A Fineberg
Differential effects of sertraline and cognitive behavioural therapy on behavioural inhibition in patients with obsessive compulsive disorder. International clinical psychopharmacology (2024)
Hernán F Guillen-Burgos, Juan F Gálvez-Flórez, Sergio Moreno-Lopez, Angela T H Kwan, Roger S McIntyre
Prospective, comparative, pilot study of maintenance treatment in comorbid bipolar disorders with post-traumatic stress disorder. International clinical psychopharmacology (2024)
Martina Arenella
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet? International clinical psychopharmacology (2024)
Louis Chevalier, Samuel Bulteau, Louis Cheval, Jalal Charron, Anne Sauvaget, Andrew Laurin
Differed spontaneous dissociative symptoms following the use of esketamine intranasal spray in a patient suffering from treatment-resistant depression: a case report. International clinical psychopharmacology (2024)
Víctor Navarro, Joana Guarch, Ilham Boulahfa, Laia Tardón, Amadeu Obach, Cristóbal Gastó, Manel Vila-Vidal
Evaluating the influence of nonproblematic alcohol intake on the outcome of major depression. International clinical psychopharmacology (2024)
Francesca Legnani, Lorenzo Tassi, Teresa Surace, Enrico Capuzzi, Alice Caldiroli, Massimo Clerici, Massimiliano Buoli
Is Pilates effective in improving depressive disorders? A comprehensive overview. International clinical psychopharmacology (2024)
Aurora Merolla, Rebecca De Lorenzo, Giacomo Paolazzi, Sara Critelli, Mariagrazia Palladini, Sarah Damanti, Giordano Vitali, Valentina Canti, Marta Cilla, Sabina Martinenghi, Elisabetta Falbo, Marica Ferrante, Jacopo Castellani, Giacomo Pacioni, Cristiano Magnaghi, Anna Fumagalli, Mario G Mazza, Francesco Benedetti, Patrizia Rovere-Querini
Micronized/ultramicronized palmitoylethanolamide improves depression and fatigue in coronavirus disease 2019 (COVID-19) survivors. International clinical psychopharmacology (2024)
Sean D Hood, Olatunji Odufowora-Sita, Jean-Baptiste Briere, Marco Lucchino, Fatma Khrouf, Elzbieta Olewinska, Paulina Pierzchala, Marwa Mezghani, Mateusz Nikodem, Pierre Lévy
Systematic review and network meta-analysis of agomelatine for the treatment of generalized anxiety disorder in adult patients. International clinical psychopharmacology (2024)
Stefano Pallanti
The role of benzodiazepines in common conditions: a narrative review focusing on lormetazepam. International clinical psychopharmacology (2024)
Yoon Cho, Ah-Young Kim, Sukhyang Lee, Hankil Lee
Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea. International clinical psychopharmacology (2024)
Nicola Dusi, Cecilia Maria Esposito, Giuseppe Delvecchio, Cecilia Prunas, Paolo Brambilla
Case report and systematic review of cerebellar vermis alterations in psychosis. International clinical psychopharmacology (2024)
Valerio Ricci, Alessandro Sarni, Giovanni Martinotti, Giuseppe Maina
Comparative analysis of third-generation antipsychotics in first-episode schizophrenia: efficacy, safety, and cognitive impacts. A narrative review. International clinical psychopharmacology (2024)
Michael E Thase, Paul P Yeung, Ludmyla Rekeda, Meng Liu, Shane Varughese
Safety and tolerability of cariprazine for the adjunctive treatment of major depressive disorder: a pooled analysis of phase 2b/phase 3 clinical trials. International clinical psychopharmacology (2024)
Clotilde Guidetti, Anna Feeney, Rebecca S Hock, Nadia Iovieno, Jesús M Hernández Ortiz, Maurizio Fava, George I Papakostas
Antidepressants in the acute treatment of post-traumatic stress disorder in adults: a systematic review and meta-analysis. International clinical psychopharmacology (2024)
Nicola Dusi, Cecilia Maria Esposito, Giuseppe Delvecchio, Cecilia Prunas, Paolo Brambilla
Case report and systematic review of cerebellar vermis alterations in psychosis. International clinical psychopharmacology (2024)
Francesca Legnani, Lorenzo Tassi, Teresa Surace, Enrico Capuzzi, Alice Caldiroli, Massimo Clerici, Massimiliano Buoli
Is Pilates effective in improving depressive disorders? A comprehensive overview. International clinical psychopharmacology (2024)
Vincenzo Cardaci, Matteo Carminati, Mattia Tondello, Basilio Pecorino, Alessandro Serretti, Raffaella Zanardi
Understanding and treating postpartum depression: a narrative review. International clinical psychopharmacology (2024)
Alice Caldiroli, Letizia M Affaticati, Enrico Capuzzi, Davide La Tegola, Fabrizia Colmegna, Massimo Clerici, Antonios Dakanalis, Massimiliano Buoli
The potential use of daridorexant in eating disorders: beyond the treatment of insomnia? International clinical psychopharmacology (2024)
Seong Hoon Jeong, Mi Gyung Lee, Yong Sik Kim, In Won Chung
Change in absolute neutrophil count after COVID-19 infection in patients using clozapine versus other antipsychotics. International clinical psychopharmacology (2024)
Ahmad Shamabadi, Hanie Karimi, Mohammad Ali Fallahzadeh, Salar Vaseghi, Razman Arabzadeh Bahri, Bita Fallahpour, Amir Hossein Abdolghaffari, Shahin Akhondzadeh
Sex-controlled differences in sertraline and citalopram efficacies in major depressive disorder: a randomized, double-blind trial. International clinical psychopharmacology (2024)

volume 39, number 3, 2024

Stefano Pallanti
The role of benzodiazepines in common conditions: a narrative review focusing on lormetazepam. International clinical psychopharmacology 39 (3) (2024)
Seong Hoon Jeong, Mi Gyung Lee, Yong Sik Kim, In Won Chung
Change in absolute neutrophil count after COVID-19 infection in patients using clozapine versus other antipsychotics. International clinical psychopharmacology 39 (3) (2024)
Alessandro Serretti
Stroke, COVID-19, and other somatic aspects of psychiatric disorders treatments. International clinical psychopharmacology 39 (3) (2024)
Seong Hoon Jeong, Mi Gyung Lee, Yong Sik Kim, In Won Chung
Change in absolute neutrophil count after COVID-19 infection in patients using clozapine versus other antipsychotics. International clinical psychopharmacology 39 (3) (2024)
Alessandro Serretti
Stroke, COVID-19, and other somatic aspects of psychiatric disorders treatments. International clinical psychopharmacology 39 (3) (2024)
Stefano Pallanti
The role of benzodiazepines in common conditions: a narrative review focusing on lormetazepam. International clinical psychopharmacology 39 (3) (2024)
Stefano Pallanti
The role of benzodiazepines in common conditions: a narrative review focusing on lormetazepam. International clinical psychopharmacology 39 (3) (2024)

volume 39, number 4, 2024

Karim Abdel Aziz, Hind Mohd Ahmed, Emmanuel Stip, Dina Aly El-Gabry
Metabolic syndrome and its relation to antipsychotic polypharmacy in schizophrenia, schizoaffective and bipolar disorders. International clinical psychopharmacology 39 (4) (2024)
Martina Arenella
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet? International clinical psychopharmacology 39 (4) (2024)
Nicola Dusi, Cecilia Maria Esposito, Giuseppe Delvecchio, Cecilia Prunas, Paolo Brambilla
Case report and systematic review of cerebellar vermis alterations in psychosis. International clinical psychopharmacology 39 (4) (2024)
Nicola Dusi, Cecilia Maria Esposito, Giuseppe Delvecchio, Cecilia Prunas, Paolo Brambilla
Case report and systematic review of cerebellar vermis alterations in psychosis. International clinical psychopharmacology 39 (4) (2024)
Martina Arenella
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet? International clinical psychopharmacology 39 (4) (2024)
Nicola Dusi, Cecilia Maria Esposito, Giuseppe Delvecchio, Cecilia Prunas, Paolo Brambilla
Case report and systematic review of cerebellar vermis alterations in psychosis. International clinical psychopharmacology 39 (4) (2024)
Yoon Cho, Ah-Young Kim, Sukhyang Lee, Hankil Lee
Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea. International clinical psychopharmacology 39 (4) (2024)
Alessandro Serretti
Focus on neurodevelopmental conditions and antipsychotics prescription patterns. International clinical psychopharmacology 39 (4) (2024)

volume 39, number 5, 2024

Anne Sauvaget, Samuel Bulteau, Andrew Laurin
It is ethical to publish successful case reports about patient with treatment-resistant depression. International clinical psychopharmacology 39 (5) (2024)
Veronika Matuskova, Martin Vyhnalek
Towards a replicable protocol to identify patients with psychiatric disorders at higher risk of developing dementia. International clinical psychopharmacology 39 (5) (2024)
Veronika Matuskova, Martin Vyhnalek
Towards a replicable protocol to identify patients with psychiatric disorders at higher risk of developing dementia. International clinical psychopharmacology 39 (5) (2024)
Alessandro Serretti
Mood disorders and somatic comorbidities. International clinical psychopharmacology 39 (5) (2024)
Anne Sauvaget, Samuel Bulteau, Andrew Laurin
It is ethical to publish successful case reports about patient with treatment-resistant depression. International clinical psychopharmacology 39 (5) (2024)
Enrico Capuzzi, Cecilia Quitadamo, Alice Caldiroli, Massimo Clerici, Massimiliano Buoli
The impact of efficacy of long-acting injectable antipsychotics on caregivers' burden of patients with schizophrenia. International clinical psychopharmacology 39 (5) (2024)
Enrico Capuzzi, Cecilia Quitadamo, Alice Caldiroli, Massimo Clerici, Massimiliano Buoli
The impact of efficacy of long-acting injectable antipsychotics on caregivers' burden of patients with schizophrenia. International clinical psychopharmacology 39 (5) (2024)